Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

EndoChoice Holdings, Inc. (GI) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2017 SC 13G/A EndoChoice Holdings, Inc. reports a 0% stake in ENDOCHOICE HOLDINGS, INC.
02/02/2017 SC 13G/A ENVEST III LLC reports a 0% stake in EndoChoice Holdings, Inc.
12/21/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
12/05/2016 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
11/28/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
11/23/2016 4 Mowry David H (Director) has filed a Form 4 on EndoChoice Holdings, Inc.
Txns: Disposed/sold 16,712 shares @ $8, valued at $133.7k
11/23/2016 4 Kaufman David L (Director) has filed a Form 4 on EndoChoice Holdings, Inc.
Txns: Acquired (by will) 1,500 shares @ $0
Disposed/sold 12,587 shares @ $8, valued at $100.7k
Disposed/sold 2,088,209 shares @ $8, valued at $16.7M
11/23/2016 4 Huennekens R Scott (Director) has filed a Form 4 on EndoChoice Holdings, Inc.
Txns: Disposed/sold 26,666 shares @ $8, valued at $213.3k
Disposed/sold 8,423 shares @ $8, valued at $67.4k
Disposed/sold 47,446 shares @ $8, valued at $379.6k
Disposed/sold 26,666 shares @ $8, valued at $213.3k
Disposed/sold 8,423 shares @ $8, valued at $67.4k
Disposed/sold 47,446 shares @ $8, valued at $379.6k
11/23/2016 4 Gilreath Mark (CEO) has filed a Form 4 on EndoChoice Holdings, Inc.
11/23/2016 4 GILL DAVID N (President and CFO) has filed a Form 4 on EndoChoice Holdings, Inc.
Txns: Disposed/sold 125,445 shares @ $8, valued at $1M
Disposed/sold 38,585 shares @ $8, valued at $308.7k
Disposed/sold 32,230 options to buy @ $5.31, valued at $171.1k
Disposed/sold 53,825 options to buy @ $16.01, valued at $861.7k
11/23/2016 4 ENQUIST WILLIAM R (Director) has filed a Form 4 on EndoChoice Holdings, Inc.
11/23/2016 4 DAVIS D SCOTT (Director) has filed a Form 4 on EndoChoice Holdings, Inc.
Txns: Disposed/sold 51,285 shares @ $8, valued at $410.3k
11/23/2016 4 Carter J Scott (Director) has filed a Form 4 on EndoChoice Holdings, Inc.
Txns: Disposed/sold 11,087 shares @ $8, valued at $88.7k
Disposed/sold 90,875 shares @ $8, valued at $727k
11/23/2016 4 BALKCOM JAMES RJR (Director) has filed a Form 4 on EndoChoice Holdings, Inc.
Txns: Disposed/sold 21,235 shares @ $8, valued at $169.9k
Disposed/sold 4,156 options to buy @ $3.32, valued at $13.8k
Disposed/sold 20,736 options to buy @ $2.83, valued at $58.7k
11/23/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/23/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/22/2016 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
11/22/2016 8-K Quarterly results
11/22/2016 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party [Amend]
11/18/2016 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party [Amend]
11/07/2016 10-Q Quarterly Report for the period ended September 30, 2016
11/04/2016 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party [Amend]
10/26/2016 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party [Amend]
10/11/2016 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
10/11/2016 SC14D9C Form SC14D9C - Written communication relating to third party tender offer
10/07/2016 SC TO-T Form SC TO-T - Tender offer statement by Third Party
10/07/2016 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements
09/27/2016 SC14D9C Form SC14D9C - Written communication relating to third party tender offer
09/27/2016 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Boston Scientific Corporation, Falcon Merger Corp. and EndoChoice Holdings, Inc. (Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish supplementally to the SEC a copy of any omitted schedule upon request.)",
"Form of Tender and Support Agreement, by and among Boston Scientific Corporation, Falcon Merger Corp. and certain of the stockholders of the Company",
"BOSTON SCIENTIFIC TO ACQUIRE ENDOCHOICE"
09/27/2016 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party
08/11/2016 EFFECT Form EFFECT - Notice of Effectiveness
08/09/2016 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
08/03/2016 8-K Quarterly results
Docs: "EndoChoice Announces Second Quarter 2016 Financial Results Alpharetta, GA, August 3, 2016 -- EndoChoice Holdings, Inc. announced today financial results for the second quarter 2016."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy